MIPLYFFA

Growth

arimoclomol citrate

NDAORALCAPSULEPriority Review
Approved
Sep 2024
Lifecycle
Growth
Competitive Pressure
8/100

Loss of Exclusivity

LOE Date
Sep 20, 2029
43 months away
Patent Expiry
Aug 19, 2029
Exclusivity Expiry
Sep 20, 2031

Patent Records (3)

Patent #ExpiryTypeUse Code
9884058
Jun 26, 2029
U-4021
9289472
Aug 11, 2029
U-4021
11045460
Aug 19, 2029
U-4021
External Resources
DailyMed
Full prescribing information
FDA Drugs@FDA
FDA approval history
RxNorm
Drug nomenclature & identifiers